Financials
- Market Capitalization 2.24 M
- Employee 2
- Founded 2013
- CEO N/A
- Website www.matinasbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG005WX2XG8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.25
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 5075 | OGEN Oragenics Inc. Common Stock | 0.58 USD | +1.75% | 0.00% | -6.45% | -8.45% | 2.62 M USD | ||
| 5083 | CLDI Calidi Biotherapeutics, Inc. Common Stock | 0.12 USD | 0.00% | -14.29% | -25.00% | -84.12% | 2.32 M USD | ||
| 5090 | PHGE BiomX Inc. COmmon Stock | 0.21 USD | -4.55% | -19.23% | -62.50% | -96.08% | 2.13 M USD | ||
| 5092 | VRAX Virax Biolabs Group Limited - Ordinary Shares | 3.57 USD | -4.55% | +21.84% | +2131.25% | +305.68% | 2.07 M USD |